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Modulation by calcitonin of magnesium and calcium urinary excretion
in the rat. We evaluated the effects of human calcitonin (hCT) on
electrolyte excretion in hormone-deprived rats, that is, in the absence
of endogenous parathyroid hormone, antidiuretic hormone,
thyrocalcitonin and glucagon, the effects of which might have interfered
with those of exogenous calcitonin. Plasma hCT levels, measured by
radioimmunoassay, varied from 0 to 32 ng/ml. In these rats, hCT
decreased magnesium (Mg) and calcium (Ca) excretion in a dose-
dependent fashion. Maximal decreases were observed for hCT plasma
concentrations comprised between 3 and 5 ng/ml, and persisted at the
highest doses. Sodium, potassium, water, and total solute excretions
were constant in the calcitonin concentration range explored. The same
was observed for phosphate, except that slight but significant
phosphaturia was elicited by the highest doses. Calcium and phosphate
infusions to attenuate the fall in plasma Ca and phosphate concentration
subsequent to hCT infusion, did not alter the hormonal effect on Ca and
Mg excretion. hCT can therefore directly modulate Mg and Ca reab-
sorption by the kidney at plasma concentrations within the physiologi-
cal range. The maximal effects on Mg and Ca reabsorption were
obtained at plasma concentrations which are generally reached after
maximal stimulation of endogenous calcitonin secretion. It is suggested
that in rats, endogenous secretion of calcitonin stimulates Ca and Mg
renal reabsorption without modification of sodium and phosphate
excretion.
Modulation de l'excrétion urinaire de magnesium et calcium par Ia
calcitonine chez le rat. Les effets de la calcitonine humaine sur
l'excrdtion des electrolytes ont étd étudiCs chez le rat anhormonal,
c'est-à-dire, en l'absence des hormones endogenes (hormone
parathyroidienne, hormone antidiurétique, calcitonine et glucagon)
dont les effets auraient Pu interferer avec ceux de Ia calcitonine
exogène. La concentration plasmatique de calcitonine, mesuree par
radioimmunologie, était comprise entre 0 et 32 nglml. Chez ces rats,
l'excrétion du magnesium (Mg) et celle du calcium (Ca) etait fonction de
Ia concentration de calcitonine circulante. Ces excretions atteignient
leur valeur minimale pour des concentrations plasmatiques de
calcitonin comprises entre 3 et 5 ng/ml, et se maintenaient a ce niveau
aux concentrations plus dlevées. L'excrétion du sodium, du potassium,
du phosphate, de l'eau et des solutés totaux dtait constante et
inddpendante de la concentration de calcitonine circulante. Cependant
aux concentrations plasmatiques les plus elevees, une phosphaturie
moddrée mais significative est apparue. La calcitonine peut donc
moduler Ia reabsorption rénale de Mg et Ca quand son taux circulant
vane dans les limites physiologiques. Les effets maximum sur Ia
reabsorption de Mg et Ca furent obtenus pour des concentrations
plasmatiques generalement atteintes après stimulation maximale de Ia
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sécrétion de calcitonine endogene. II est suggCré que la secretion de
calcitonine endogene induit chez le rat une augmentation de la
reabsorption rénale du magnesium et du calcium sans modification de
l'excrëtion du sodium et du phosphate.
The renal effects of calcitonin in mammals have been widely
studied on both intact and thyroparathyroidectomized animals.
It is now established that salmon, porcine, and human
calcitonin (hCT) reduce the renal excretion of calcium (Ca) and
magnesium (Mg). For human and salmon calcitonin, these
effects result from stimulation of the transport of these two ions
out of the thick ascending limb [1—3]. The thick ascending limb
of Henle's loop is, however, a target site for many other
hormones, including peptidic hormones such as vasopressin
(ADH), glucagon, and parathyroid hormone (PTH) [4]. The
renal effects of each of these hormones in the absence of a
possible interference from the others [41 have recently been
investigated in the rat. It was demonstrated on these hormone-
deprived rats (DI Brattleboro rats lacking ADH, acutely
thyroparathyroidectomized to suppress thyrocalcitonin and
parathyroid hormone and given glucose [51or somatostatin [3,
5, 61 to inhibit endogenous glucagon secretion) that each of the
four hormones in question clearly enhanced renal reabsorption
of Ca and Mg, and that these effects directly resulted from the
stimulation of Ca and Mg transport both by the thick ascending
limb [3, 5, 6] and, to a lesser extent, by the convolutions of the
distal tubule accessible to micropuncture. Indeed, very recent
micropuncture experiments clearly showed that dDAVP (a
synthetic ADH analog), PTH, hCT, and glucagon enhanced Ca
reabsorption and that PTH, hCT, and glucagon enhanced Mg
reabsorption in this part of the distal tubule [7—9].
The purpose of this study was to establish dose-response
relationships for the renal effects of calcitonin to determine the
range of plasma concentrations within which variations in Ca
and Mg excretion are observed. Administration of calcitonin
lead to reductions of Ca and phosphate plasma concentrations.
To prevent these considerable decreases the rats were given Ca
and/or phosphate simultaneously with calcitonin infusions. In
two groups of rats, however, the falls in plasma Ca and
phosphate concentrations were not corrected so that the spe-
cific renal effects of calcitonin could be better distinguished
from those resulting from modifications of the plasma composi-
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tion. Human calcitonin was chosen because its chemical struc-
ture is very close to that of rat calcitonin [10] and because its
immuno-reactivity is identical to that of rat calcitonin permit-
ting precise plasma concentration determinations. The experi-
ments were conducted on hormone-deprived rats to obtain the
specific renal response of calcitonin in the absence of undesir-
able interference from the other peptidic hormones.
Methods
Clearance experiments were performed on 45 male rats with
hereditary hypothalamic diabetes insipidus (DI), weighing 180
to 230 g and bred in our laboratory. Laboratory chow of
constant composition (UAR France, Mg, 0.112 g; Ca, 0.97 g; P,
0.85 g per 100 g) was available to all rats until 17 hr before the
experiments, at which time, the animals were put into metabolic
cages to verify from their urine osmolality and output that they
were homozygous (that is, DI). Free access to distilled water
was allowed until anesthesia. Rats were anesthetized by the
administration of 10 mgIlOO g body wt of sodium 5 ethyl-5 (I'
methyl-propyl)-2-thiobarbiturate (Inactin-Byk, Byk Gulden
Konstanz, Federal Republic of Germany) and were then placed
on a heated table to maintain body temperature at 37°C. Rats
underwent tracheotomy, after thyroparathyroid glands were
removed if necessary. For perfusion of solutions, one PE 50
catheter was inserted into the right jugular vein and another into
the right femoral vein (and sometimes also into the left femoral
vein). One PE 50 catheter was inserted into the right femoral
artery for arterial blood sampling and PE 50 catheters were
inserted into the left and right ureters for urine collection.
Estimated fluid losses were replaced by intravenous injec-
tions of 0.9% NaC1 (1.5 ml/l00 g body wt) administered once
during the middle and once at the end of surgery. Then, at time
zero, each animal was infused through the jugular catheter, at
10 min'/lOO g body wt, with an 0.4% NaCl solution
containing 3H-inulin (infused at 0.2 pCi/mm) somatostatin (Clin-
Midy, 93537) and when necessary, calcitonin plus bovine serum
albumin (1 mg/ml, BSA fraction V).
All animals were also infused through the right femoral vein
catheter with a 0.4% NaCl solution at 30 d1min/l00 g, a rate
fixed at the beginning of the experiments. The clearance periods
began after a 60-mm equilibration period during which urine
samples from both kidneys were collected. Eight rat groups
were studied. They comprised one group of intact DI rats, one
of hormone-deprived rats and six of hormone-deprived rats
infused with human calcitonin. The hormone-deprived rats
were DI Brattleboro rats (that is, without circulating ADH)
acutely thyroparathyroidectomized to suppress circulating PTH
and calcitonin, and infused with somatostatin (70 ng/min/lOO g
body wt) to inhibit glucagon secretion [11]. Synthetic human
calcitonin (Cibacalcin R, C47 175 Ba) was administered to such
hormone-deprived rats at rates of 0.10, 0.25, 1.00, and 2.5
mU/min/l00 g body wt, respectively. The group receiving 2.5
mU/min/lOO g body wt was given phosphate (50 mM Na2HPO4
and 10 m Na H2P04 at 5 il/min/l00 g body wt) through the
jugular vein and calcium (50 mrvi CaCl2, at 5 pi/min/lOO g body
wt) through the left femoral vein catheters. The group receiving
1.00 mU calcitonin/min/l00 g body wt was given the same
phosphate infusion, but the administration rate of calcium was
halved (25 mrvi CaC12 and 31 mrvi NaC1 at 5 jl/min/l00 g body
wt). These infusions were designed to prevent the plasma
phosphate and calcium concentrations from falling after
calcitonin administration. The reduction of Ca and Mg excre-
tion subsequent to hCT administration was already maximal at
1.00 mU/min/l00 g body wt (see Results). It was therefore of
interest to explore the effects of hCT on the renal function at
infusion rates of the hormone below 1.00 mU/minIlOO g body
wt, that is, at submaximal doses. To distinguish better between
the direct hormonal effects on the tubular function and the
indirect influence of the accompanying hypocalcemia and
hypophosphatemia on these functions, four groups of hormone-
deprived rats were studied. In two groups hCT was adminis-
tered at 0.1 and 0.25 mU/min/100 g body wt without simultane-
ous Ca and phosphate infusions. At 0.1 mU, a large decrease in
plasma Ca was observed, and a further decrease in plasma
phosphate was noted at 0.25 mU. We decided to correct these
modifications independently. In two other groups hCT was
therefore administered at 0.1 and 0.25 mU/min/l00 g body wt; at
0.1 mU the rats received a (25 mti CaC12, 31 mrvi NaC1) solution
at 5 dImin/l00 g body wt to attenuate the plasma Ca decrease
and at 0.25 mU the rats received a phosphate solution (50 mM
Na2HPO4 + 10 mM Na H2PO4) at 5 jd/min/l00 g body wt to
correct the phosphate plasma decrease.
The experiments consisted of five 30-mm clearance periods,
the first of which started 210 mm after tracheotomy. After each
blood collection, samples were centrifuged, the plasma was
separated and the red blood cells were resuspended for reinjec-
tion through the femoral vein catheter [5]. The urinary flow rate
of both kidneys was determined after each urine collection and
the rate at which the 0.4% NaC1 solution was administered was
adjusted to compensate for water losses. At the end of each
experiment the hematocrit was measured and a blood sample
taken for calcitonin radioimmunoassay. The kidneys were then
removed and weighed after removal of their perirenal fat.
Analytical procedures
Plasma calcitonin was measured by an RIA described previ-
ously [12]. Briefly, synthetic human calcitonin (Ciba-Geigy AG
Basel, Switzerland) was used for labeling with 125J by the
chloramide T method [13]. The labeled hormone was purified by
gel filtration on Sephadex G-50 (fine). Specific activities of 250
to 350 jsCiIjg were obtained routinely. The antiserum produced
in a sheep against synthetic human calcitonin was shown to
cross-react with rat calcitonin [12]. Barbital buffer (0.025 M;
pH, 8.6) containing peptidase inhibitors was used as diluent.
Incubation mixtures were prepared in duplicate in a total
volume of 0.4 ml containing 0.02 ng labeled human calcitonin
and a final dilution of the antiserum of 1:80,000 to give 40 to 60%
binding of the labeled hormone; 0.1 ml of standard human
calcitonin or of a sample with an unknown calcitonin concentra-
tion was added. Nonspecific binding was estimated in all assays
for both unknown samples and standard curves (in the latter
case, 0.1 ml of calcitonin-free plasma from thyroparathyroid-
ectomized rats was added). Tubes were incubated in an equi-
librium system at 4°C for 6 days. Bound and free radioactivity
were separated on plasma-coated charcoal. The limit of detec-
tion of the assay was 0.15 ng calcitoninlml plasma.
To determine the 3H-inulin concentration S-p.l samples of
urine and plasma were separately dissolved in Picofluor scintil-
lating solution (Packard Instruments, Downers Grove, Illinois,
USA), and radioactivity was measured by liquid scintillation
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Table I. Plasma concentration of calcitonin in hormone-deprived and
hormone-deprived plus human calcitonin ratsa
Plasma calcitonin
ng/ml
RD rats NS
(8)
HO + hCT 0.83 0.09
0.1 mU/,nin/100 g body wt
(11)
HO + hCT 2.87 0.21
0.25 mU/min/l0O g body wt
(II)
RD + hCT 11.76 2.13
1.00 mU/min/100 g body wt
(5)
RD + hCT 30.33 1.20
2.50 mU/min/100 g body wt
(3)
Abbreviations: NS, not significantly different from the detection
threshold of the assay (0.15 nglml); HO, hormone-deprived rats; hCT,
human calcitonin.
a Values are mean 5EM; the number of rats is in parentheses.
counting (Intertechnique SL 4000). Na and K concentrations
were measured in both plasma and urine by flame-emission
photometry (Netheler and Hinz), the Ca and Mg concentrations
by atomic absorption photometry (Instrumentation Laboratory
353), and the phosphate concentration, by the method of Chen,
Toribara, and Warner [14J. Osmotic pressure was determined in
urine samples with a 5100 C vapor pressure osmometer (Wascor
Inc.) and in plasma samples by microcryometry [15].
At the end of each experiment the water balance was esti-
mated by comparing the amounts of water administered with
the urinary losses; the difference was expressed as a percentage
of the body weight. The values for all the parameters measured
in plasma and urine were averaged and considered as a single
datum for each animal. Data are presented as means SE.
Results were analyzed by Student's unpaired t test.
Results
Table 1 gives the mean plasma calcitonin concentrations
measured in five rat groups comprising hormone-deprived rats
and hormone-deprived + hCT rats. As expected, the lowest
concentration was observed in the hormone-deprived rats, and
was not significantly different from the limit of detection of the
radioimmunoassay (0.15 ngfml). The concentration of circulat-
ing calcitonin rose with the administration rate of this hormone.
The increase in the plasma calcitonin concentration was pro-
portional to the dose (Fig. 1).
Tables 2, 3, and 4 present the data obtained in intact Dl and
hormone-deprived rats plus the two groups of hormone-
deprived rats receiving the highest doses of hCT (I and 2.5
mU/mini 100 g body wt).
The water balance was not significantly different from zero in
any of the four groups, indicating that the urinary water losses
were adequately replaced (Table 2). This was corroborated by
the unchanged hematocrit values which remained identical to
V
0/mm
GFRIg kidney wt
p1/mm
Water balance
% body wt
DI intact
(5)
46.7 1023 0.6
HD rats
(8)
41.1 850 0.9
HO + hCT (with Ca ÷ Pi)
1.00 mU/mm/IOU g body wt
(5)
40.6 l230 0.9
RD + hCT (with Ca + Pi)
2.50 mU/mm/IOU g body wt
(5)
46.4 luSh 0.6
Abbreviations: GFR1g kidney wt, glomerular filtration rate per gram
of kidney weight; DI, diabetes insipidus; hCT, human calcitonin; Ca,
calcium; Pi, inorganic phosphorus.
a Values from five clearance periods were averaged and considered
as one datum for one animal. Means are given with their s; the number
of rats is in parentheses.
Unpaired t test between either hormone-deprived and intact, or hor-
mone-deprived and hormone-deprived + hCT rats: b 0.025 <Pc 0.05;
0.01 <F < 0.025.
that of unanesthetized DI rats (0.45 0.01, data not shown). As
shown in Table 2, the glomerular filtration rate (GFR) was
slightly but not significantly depressed by the hormone depriva-
tion but was enhanced by administration of hCT. The urinary
flow rate was high and was not changed by calcitonin, and
fractional water excretion was roughly the same in all four
groups. In the plasma (Table 3) the phosphate concentration
was higher and the Mg and Ca concentrations were lower in
y = 1.11 x —0.28
= 0.999
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Fig. 1. Correlation between immunoreactive plasma calcitonin and the
administration rate of human calcitonin to hormone-deprived rats. The
points are mean values obtained from the 30 animals (see Table 1). 5EM
were smaller than the point diameters.
Table 2. Urinary flow rate, CIFR, and water balance in intact diabetes
insipidus rats, hormone-deprived rats and hormone-deprived rats
receiving the two highest doses of human calcitonina
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Table 3. Plasma composition (mmoles liter or mOsm kg 1) in
intact diabetes insipidus rats, hormone-deprived rats and hormone-
deprived rats receiving the two highest doses of human calcitonina
Na Pi Mg Ca K Osm
DI intact
(5)
144 2.52c 0.72c 2.3P' 4.00 311
HD rats
(8)
149 3.60 0.54 2.07 3.88 312
HD + hCT (with Ca+ Pi)
1.00 mU/min/100 g body wt
(5)
149 3.0l 0.63k' 1.91 3.93 311
HD hCT (with Ca + Pi)
2.50 mUImin/100 g body wt
(5)
149 3.19c 0.64 2.26 3.76 316
Abbreviations: DI, diabetes insipidus; HD, hormone deprived; hCT,
human calcitonin; Ca, calcium; Pi, inorganic phosphorus; Na, sodium;
Mg, magnesium; K, potassium; Osm, osmolality.
a Values from five clearance periods were averaged and considered
as one datum for one animal. Means are given with their sE; the number
of rats is in parentheses.
Unpaired t test between either hormone-deprived and intact, or hor-
mone-deprived and hormone-deprived + human calcitonin rats: b P
0.05; P < 0.01.
Table 4. Electrolyte and total solute excretion rate (nmoles min or
mOsm min) in intact diabetes insipidus rats, hormone-deprived rats
and hormone-deprived rats receiving the two highest doses of human
calcitonina
Na Pi Mg Ca K Osm
DI intact
(5)
783 398b 43.1 57b 532 5301
HD rats
(8)
1425 42 44.1 55.0
10.3
527 7059
1358
HD + hCT (with Ca+ Pi)
1.00 mUIminIlOO g body wt
(5)
827 76 8.8b 53b 405 6376
HD hCT (with Ca + Pi)
2.5OmUImin/l00gbodywt
(5)
1931 182b lO.2b 6.4b 573 8403
Abbreviations are the same as those used in Table 3.
a Values from five clearance periods were averaged and considered
as one datum for one animal. Means are given with their SE.
Unpaired t test between either hormone-deprived and intact or hor-
mone-deprived and hormone-deprived plus human calcitonin rats: b P <
0.01.
hormone-deprived than in intact DI animals, as already ob-
served [5]. Between the hormone-deprived and hormone-
deprived + hCT rats, no significant differences were found as
regards Na, K, and total solutes. The administration of hCT to
such hormone-deprived rats tended to raise the plasma Mg
concentration but to values lower than those of intact DI rats.
The plasma Ca concentration did not differ significantly from
that of the hormone-deprived group; the phosphate concentra-
tions were lower than those of this latter group, but
phosphatemia was nevertheless high (higher than that of intact
DI rats).
Table 5. Urinary flow rate, GFR, and water balance in hormone-
deprived rats receiving the two lowest doses of human calcitonin
V GFRIg kidney wt Water balance
pd/mm pd/mm % body wt
HD + hCT (without Ca)
0.1 mU/min/100 g body wt
(7)
50.1
NS
1019
NS
0.4
NS
HD + hCT (with Ca)
1.00 mU/min/100 g body wt
(4)
51.9 1002 0.2
HD + hCT (without Pi)
0.25 mUlmin/100 g body wt
(5)
39.0
NS
1107
NS
—0.2
NS
HD + hCT (with Pi)
0.25 mU/min/100 g body wt
(6)
39.2 1045 1.8
Abbreviations: NS, not significant; other abbreviations are the same
as those used in Tables 2 and 3.
a Values from five clearance periods were averaged and considered
as one datum for one animal. Means are given with their sE; the number
of rats is in parentheses. Unpaired t test between HD + hCT with
versus without Ca and with versus without P.
Hormone deprivation and administration of calcitonin con-
siderably modified the excretion of electrolytes (Table 4). For
magnesium, the excretion in the two groups receiving the
largest doses of calcitonin was significantly lower than in the
hormone-deprived group. Hormone-deprivation consistently
raised calcium excretion, and administration of calcitonin re-
duced it to the rate measured in the intact DI rats. As regards
Na, K, and total solutes, excretion rates did not differ signifi-
cantly from one group to another. Phosphate excretion fell
considerably in the hormone-deprived animals. hCT at 1.0
mU/min/l0O g body wt did not modify this excretion. At 2.5
mU/min/l00 g body wt a phosphaturic effect was noted.
Tables 5 and 6 present the data obtained from hormone-
deprived rats receiving the lowest doses of hCT (0.1 and 0.25
mU/min!100 g body wt) infused or not with Ca or phosphate.
Table 5 shows that the urinary flow rate and the glomerular
filtration rates were very similar, irrespective of the administra-
tion of Ca or phosphate. The water balance was close to zero in
all four groups. Table 6 indicates the plasma composition and
the electrolyte excretion rates. In all four groups the
magnesemia was similar. The Mg and Ca excretion rates were
not significantly different whether the drop in calcemia (0.1 mU
groups) or in phosphatemia (0.25 mU groups) was corrected or
not. In addition, these excretion rates were significantly lower
in the 0.1 mU groups than in the hormone-deprived animals and
even lower in the 0.25 mU groups. Phosphaturia was as low as
that observed in the hormone-deprived rats, except in the 0.25
mU group which received a phosphate infusion. In this group,
as in the 1.0 and 2.5 mU groups that also received phosphate,
the phosphaturia was extremely variable from one animal to
another. The plasma concentration and excretion rates of Na,
K, and total solutes were similar to those observed in the
hormone-deprived rats (data not shown).
In conclusion, it is clear that the reductions in Ca and Mg
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HD+hCT
0.1 mUIminIlOO hody wt
HC
0.25 mU/mi
+hCT
n/lOU g body wt
Without Ca
(7) P
With Ca
(4)
Without Pi
(5) P
With Pi
(6)
3.08 NS 3.08 2.79 <0.01 3.48
UV 11.9 NS 4.1 10.0 NS 67.7
PM5 0.57 NS 0.62 0.61 NS 0.56
UVMg 33.7 NS 25.5 10.4 NS 11.0
Pca 1.62 <0.001 1.97 1.78 NS 1.62
UV 19.5 NS 27.6 5.6 NS 9.5
excretion are the results of a direct effect of CT on the tubular
functions. As illustrated in Figure 2, the renal excretion of Mg
and Ca was clearly related to the plasma CT concentration. The
excretion rates followed a dose response curve. Between 0 and
5 ng/ml, Mg and Ca excretion decreased sharply and then
leveled off. This indicates that Ca and Mg tubular reabsorptions
were maximally stimulated when the plasma hCT concentration
was around 5 nglml.
Discussion
The present study demonstrates that synthetic human
calcitonin produced maximal reductions in calcium and magne-
sium excretion in hormone-deprived rats when plasma
calcitonin concentrations reached 3 to 5 ng/ml. Above these
levels and up to 30 ng/ml, no further changes in Ca and Mg
excretion were observed. Na, K, or total solute excretion
remained roughly constant, irrespective of the plasma
calcitonin concentration. Phosphate excretion was low in these
hormone-deprived animals because of parathyroid gland abla-
tion, but tended to rise when the plasma calcitonin exceeded 15
ng/ml.
Calcitonin increased the GFR, as has been frequently ob-
served [1, 3, 16, 17]. This increase was accompanied by a rise in
the filtered load of electrolytes. Nevertheless, Ca and Mg
excretion gradually fell as a function of the circulating level of
calcitonin. Calcitonin administration generally induces marked
hypocalcemia. It appears that hypocalcemia could enhance
sodium chloride reabsorption in the thick ascending limb [2].
Two mechanisms could be involved. There is evidence that
cytostolic Ca activity may directly alter the rate of luminal
sodium entry [18], and recently Di Stefano et al [19] demon-
strated that an increase of the extracellular Ca concentration
Plasma CT. ng/m!
Fig. 2. Relationship between Mg and Ca excretion by the kidney and
plasma immunoreactive calcitonin. Each point is the mean value of five
clearance periods from different animals. Mean values for rats with a
plasma CT less than 0.15 ng/ml are given with their SE.
inhibits active sodium chloride reabsorption in microperfused
rabbit cortical thick ascending limb by a reduction in paracel-
lular Na conductance. It is conceivable, therefore, that hypo-
calcemia is accompanied by a rise of sodium chloride transport
and hence of Ca and Mg reabsorption if, as is likely, sodium
chloride and divalent cation transports by the thick ascending
limb are linked. Such a rise could be responsible for the
reduction of Mg and Ca urinary output during hCT administra-
tion. The present experiments, however, show that the de-
creases in Ca and phosphate plasma concentration were not
sufficient to significantly influence the Ca and Mg excretion
rates. This was already observed by Carney and Thomson [17]
who reported that calcium infusion prior to salmon calcitonin
administration to prevent a detectable drop in plasma Ca
concentration did not influence the reduction of Ca and Mg
excretion. It is therefore safe to conclude that the reduction in
Mg and Ca excretion was the result of a direct effect of
calcitonin on the kidney. This conclusion is supported by the
existence along the nephron of target sites for calcitonin [20],
including, in the rat, the thick ascending limb, the distal
convoluted tubule, and the cortical collecting ducts [21]. It is
further corroborated by recent data which demonstrate that in
Table 6. Plasma composition (P, mmoles/liter) and electrolyte
excretion rate (UV, nmoles/min) in hormone-deprived rats receiving
the two lowest doses of human calcitonina
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hormone-deprived rats, calcitonin, like ADH, stimulates cal-
cium and magnesium reabsorption mainly in the ioop of Henle
[3] and, to a lesser extent in the part of the distal tubule
accessible to micropuncture [7].
Mg and Ca reabsorption by the kidney was maximally stimu-
lated; as already mentioned, when the plasma calcitonin con-
centration reached 3 to 5 nglml. In the normal rat, full stimula-
tion of endogenous calcitonin release by calcium infusion
increased the level of circulating calcitonin to values around 10
ng/ml [221. The fact that variations of the plasma calcitonin
concentration within physiological limits were observed to
modulate Mg and Ca transport by the kidney is satisfactory. In
DI nonfasted Brattleboro rats, the basal calcitonin concentra-
tion is 0.62 0.09 ng/ml (N = 5) (unpublished observations), a
value which confirms previous measurements by others in this
strain [23]. This probably explains in part why Ca excretion was
lower in intact DI rats than in the hormone-deprived rats. The
influence of the other peptidic hormones, that is, PTH and
glucagon, known to stimulate Ca and Mg reabsorption in the
loop of Henle [6] and the distal tubule [9], cannot be excluded.
It is now clearly established that moderate doses of salmon
and mammalian calcitonins can reduce renal Mg and Ca excre-
tion [3, 17, 24, 251. The effects of calcitonins on Na and
phosphate excretion were very often controversial. Some au-
thors found that calcitonin did not affect excretion of these two
ions, whereas others observed either phosphaturia or
natriuresis, or both (see [17]). In some instances, calcitonin
even reduced phosphaturia [1]. As is now generally acknowl-
edged, these conflicting results could be due to the doses [17,
24] and/or the nature of the hormonal preparation used. It is
possible that the discrepancies were also due to the interference
of the other peptidic hormones which act via activation of the
adenylate-cyclase system.
Williams et al [24] examined, in intact rats, the dose-response
relationship of human calcitonin on the renal handling of
electrolytes. The administration rate ranged from 0.4 to 24
mU/min/lOO g body wt. In these rats, the decrease in Mg
fractional excretion was already maximal at 0.4 mU/min!lOO g
body wt, which agrees with our data, whereas calcium excre-
tion only declined after doses equal to or higher than 1.6
mU/min/lOO g body wt. Phosphate and sodium excretion were
unaltered, irrespective of the calcitonin dose.
In other investigations of such dose-response relationships,
salmon or porcine calcitonin was used [17, 24—26]. According to
Williams et al [24], the action of salmon calcitonin on renal
electrolyte excretion in the rat compared with that of human
calcitonin might be different from the relative hypocalcemic
potencies of the two hormones. In addition, we found that
salmon calcitonin administered at 2.5 mU/min/100 g body wt to
hormone-deprived rats reduced both the absolute and the
fractional excretion of water, despite a concomitant increase in
GFR, and raised the urinary osmolality [27]. Such an
antidiuretic response to salmon calcitonin administration was
also reported by Carney et al [28]. As indicated here, human
calcitonin administered at the same rate as salmon calcitonin
was without effect on both water excretion and urine osmolal-
ity. The precise renal activity of salmon calcitonin in relation to
that of human calcitonin, therefore, remains to be established.
Almost nothing is known about the relative potencies of human
and porcine calcitonin. It is therefore difficult to draw precise
conclusions from a comparison of our data with those obtained
for salmon or porcine calcitonin [17, 25, 26].
Finally, this work shows that in hormone-deprived rats,
variations in the plasma calcitonin concentration within the
physiological range can modulate Ca and Mg excretion. It is
very likely that such a precise dose-response relationship was
obtained thanks to the absence of the other peptidic hormones
(ADH, PTH, and glucagon) which can also stimulate Mg and Ca
reabsorption in the thick ascending limb and the distal tubule.
In the intact animal, the presence of these hormones would
certainly have obscured the response, as illustrated by the fact
that Ca excretion was already at its minimum in the intact DI
rats. Administration of exogenous calcitonin could not feasibly
reduce Ca excretion further. In intact antidiuretic Wistar rats,
we previously observed that fractional Mg excretion was very
low [I]. There again, the possibility that exogenous calcitonin
could further reduce Mg excretion is very slight. Hence, one
might question the physiological significance of our observa-
tions. That the effects of calcitonin ([3] and present study),
ADH [5], and glucagon [6] on renal thick ascending limb and
distal tubule [7—9] functions were shown at plasma concentra-
tions within the physiological range provides a necessary con-
dition for such effects to be of significance. In addition, it must
be emphasized that, although the stimulatory effect of ADH on
Mg reabsorption by the kidney was first revealed in hormone-
deprived animals identical to those used in the present study
[5], it has since been clearly demonstrated that ADH either
when administered acutely [29] or chronically [30] acts also on
Mg excretion in intact DI Brattleboro rats. By analogy we
therefore believe that the sharp modulation by calcitonin of
renal Ca and Mg excretion observed in hormone-deprived rats
is not devoid of physiological significance, and a search for the
physiological or physiopathological conditions under which this
modulation might be expressed is clearly warranted.
Acknowledgments
Part of this work was presented at the Reunion Specialisee de
l'Association des Physiologistes, Lyon, France, February 21—23, 1983.
The authors thank P. Philippe and N. Soyeux for technical assistance
and M. N. Dodds for secretarial assistance.
Reprint requests to Dr. C. de Rouffignac, DBILPPC, C.E.N. Saclay,
91191 Gif-sur-Yvette, France
1. PoUJEOL P, TOUVAY C, ROINEL N, DE ROUFFIGNAC C: Stimulation
of renal magnesium reabsorption by calcitonin in the rat. Am J
Physiol 239:F524—F532, 1980
2. QUAMME GA: Effect of calcitonin on calcium and magnesium
transport in rat nephron. Am J Physiol 238:E573—E578, 1980
3. ELALOUF JM, R0INEL N, DE ROUFFIGNAC C: ADH-like effects of
calcitonin on electrolyte transport by Henle's loop of rat kidney.
Am J Physiol 246:F2l3—F220, 1984
4. MOREL F, CFIABARDES D, IMBERT-TEHOUL M, LE BOUFFANT F,
HUS-CITHAREL A, MONTEGUT M: Multiple hormonal control of
adenylate cyclase in distal segments of the rat kidney. Kidney mt
21:55—62, 1982
5. 1F ROUFFIGNAC C, CORMAN B, ROINEL N: Stimulation by
antidiuretic hormone of electrolyte tubular reabsorption in rat
kidney. Am J Physiol 244:156—164, 1983
6. BAILLY C, ROINEL N, AMIEL C: PTH-like glucagon stimulation of
Ca and Mg reabsorption in Henle's loop of the rat. Am J Physiol
246:F205—F2l2, 1984
7. ELALOUF JM, ROINEL N, DE ROUFFIGNAC C: Stimulation by
human calcitonin of electrolyte transport in distal tubules of rat
kidney. PflugersArch 399:111—118, 1983
400 Di Stefano et a!
8. ELALOUF JM, ROINEL N, DE ROUFFIGNAC C: Effects of
antidiuretic hormone on electrolyte reabsorption and secretion in
distal tubules of rat kidney. Pflugers Arch 901:167—173, 1984
9. BAILLY C, R0INEL N, AMIEL C: Stimulation by glucagon and PTH
ofCa and Mg reabsorption in the superficial distal tubule of the rat
kidney. Pflugers Arch, in press
10. RAULAIS D, HAGAMAN J, ONTJES DA, LUNBLAD RL, KINGDON
HS: The complete aminoacid sequence of rat thyrocalcitonin. EurJ
Biochern 64:607—611, 1976
11. EFENDIC S, LINs PE, LUFT R: Somatostatin and insulin secretion.
Metab 27(suppl 1): 1275—1281, 1978
12. GAREL JM, BESNARD P, BONNETON—REBUT C: C-cell activity
during the prenatal and postnatal periods in the rat. Endocrinology
109:1573—1577, 1981
13. HUNTER WM, GREENWOOD FC: Preparation of '251-labeled human
growth hormone of high specific activity. Nature 194:495—496, 1962
14. CHEN PS, TORIBARA TY, WARNER H: Microdetermination of
phosphorous. Anal Chem 28:1756—1758, 1956
15. RAM5AY JA, BROWN RH: Simplified apparatus and procedures for
freezing point determinations upon small volumes of fluid. J Phys
[El 32:372—375, 1955
16. PAILLARD F, ARDAILLOU R, MALENDIN H, FILLASTRE JP, PRIER
S: Renal effects of salmon calcitonin in man. J Lab Gun Med
80:200—216, 1972
17. CARNEY S, THOMPSON L: Acute effect of calcitonin on rat renal
electrolyte transport. Am J Physiol 240:F12—F16, 1981
18. TAYLOR A, WINDHAGER EE: Possible role of cytosolic calcium and
Na-Ca exchange in regulation of transepithelial sodium transport.
Am J Physiol 236:505—512, 1979
19. Di STEFANO A, WITTNER M, GEBBLER B, GREGGER R: IncreasedCa + or Mg + reduces the Na-eonductance of the paracellular
pathway in isolated perfused cortical thick ascending limb of Henle
loops (cTAL) of rabbit kidney (abstract). Pflugers Arch
400(suppl):R21, 1984
20. CHABARDES D, IMBERT—TEBOUL M, MONTEGUT A, CLIQUE A,
MOREL F: Distribution of calcitonin-sensitive adenylate cyclase
activity along the rabbit kidney tubule. Proc Nat! Acad Sci USA
73:3608—3612, 1976
21. MOREL F, IMBERT—TEB0UL M, CHABARDES D: Distribution of
hormone-dependent adenylate cyclase in the nephron and its physi-
ological significance. Ann Rev Physiol 43:569—581, 1981
22. CRESSENT M, BouIzAR Z, PIDOUX E, MOUKHTAR MS, MILMAUD
G: Effect of ovariectomy on plasma calcitonin levels in the rat. CR
Hebd Seances Acad Sci, Ser D 289(5):501—504, 1979
23. VAN HOUTEN M, Rizzo AJ, GOLTZMAN D, POSNER BI: Brain
receptors for blood borne calcitonin in rats: Circumventricular
localization and vasopressin-resistant deficiency in hereditary Dia-
betes Insipidus. Endocrinology 111:1704—1710, 1982
24. WILLIAMs CC, MATTHEWS EW, MOSELEY JM, MACINTYRE I: The
effects of synthetic human and salmon calcitonins on electrolyte
excretion in the rat. Clin Sci 42:129—137, 1972
25. NIELSEN SP, BUCHANAN-LEE B, MATTHEWS EW, MOSELEY JM,
WILLIAMS CC: Acute effects of synthetic porcine calcitonins on the
renal excretion of magnesium, inorganic phosphate, sodium and
potassium. J Endocrinology 51:455—464, 1971
26. BERNDT TJ, KNOX FG: Effects of parathyroid hormone and
calcitonin on electrolyte excretion in the rabbit. Kidney mt
17:473—478, 1980
27. DE ROUFFIGNAC C, ELALOUF JM: Effects of salmon calcitonin on
the renal concentrating mechanism. Am J Physiol 245:F506—F51 1,
1983
28. CARNEY S, MORGAN T, RAY C, THOMSON L: Effect of calcitonin on
urine concentration in the rat. Am J Physiol 244:F432—F435, 1983
29. DE ROUFFIGNAC C, ELALOUF JM, Di STEFANO A: Renal effects of
ADH on water permeability and electrolyte transport: Evidence for
different thresholds of stimulation, in Abs XXIXth mt CongrPhys
Sci, Sydney 1983
30. BANKIR L, BOUBY N, TRINH-TRANG-TAN MM: Effects of ADH on
renal handling of electrolytes: evidence for a role in Ca and Mg
excretion in the conscious rat (abstract). Kidney mt 25:294, 1984
